The Role of Antibiotics After Surgical Treatment of Simple Hand Infections: A Prospective Study

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Dr. Theodora Manoli, BG Trauma Center Tuebingen
ClinicalTrials.gov Identifier:
NCT01429571
First received: September 1, 2011
Last updated: September 6, 2011
Last verified: September 2011
  Purpose

Three patient groups with simple hand infections are tested regarding the necessity of antibiotics after surgical treatment.


Condition Intervention
Hand Infections
Other: No intervention

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by BG Trauma Center Tuebingen:

Enrollment: 90
Study Start Date: August 2009
Study Completion Date: December 2010
Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Systemic and local antibiotics Other: No intervention
No intervention
Other Name: Since our study was observational after the beginning of treatment with or without antibiotics no intervention was influenced by the study.
Local antibiotics Other: No intervention
No intervention
Other Name: Since our study was observational after the beginning of treatment with or without antibiotics no intervention was influenced by the study.
No antibiotics Other: No intervention
No intervention
Other Name: Since our study was observational after the beginning of treatment with or without antibiotics no intervention was influenced by the study.

  Eligibility

Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Adult patients with simple hand infections (no infection of the bone, tendon or joint)

Criteria

Inclusion Criteria:

  • Adult patients with simple hand infections

Exclusion Criteria:

  • Infection of the bone, tendon or joint
  • Major diseases like diabetes or immunodeficiency
  • Systemic manifestations like fever or lymphangitis
  • Bite infections
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01429571

Locations
Germany
BG Trauma Center
Tuebingen, Germany, 72076
Sponsors and Collaborators
BG Trauma Center Tuebingen
  More Information

No publications provided

Responsible Party: Dr. Theodora Manoli, MD, BG Trauma Center Tuebingen
ClinicalTrials.gov Identifier: NCT01429571     History of Changes
Other Study ID Numbers: Antibiotics in hand infections
Study First Received: September 1, 2011
Last Updated: September 6, 2011
Health Authority: Germany: Ethics Commission

Additional relevant MeSH terms:
Anti-Bacterial Agents
Antibiotics, Antitubercular
Anti-Infective Agents
Therapeutic Uses
Pharmacologic Actions
Antitubercular Agents

ClinicalTrials.gov processed this record on April 22, 2014